Dr. Ashkan Emadi, MD, PhD, is a nationally recognized physician-scientist specializing in hematologic malignancies, with a focus on acute myeloid leukemia (AML) and cancer metabolism. He serves as the Alexander Bland Osborn Distinguished Professor and Chair of the Department of Medical Oncology at the West Virginia University Cancer Institute, where he also holds leadership roles as Physician-in-Chief for Medical Oncology and Associate Director for Translational Research. Dr. Emadi received his medical degree from Tehran University of Medical Sciences and earned a PhD in organic chemistry from the Illinois Institute of Technology. He completed his residency in internal medicine at the University of Cincinnati and fellowship training in hematology and oncology at Johns Hopkins University. He is board-certified in Hematology and Medical Oncology and is widely regarded for his translational research in leukemia and amino acid-targeted cancer therapies.
Why they are a top doctor
Research papers · PubMed
119
Published, peer-reviewed work, the clearest public measure of expertise in a specialty.
Cited by other doctors
5.2k
How often other doctors and researchers build on their work.
Background
Education
Medical school: Tehran University of Medical Sciences, Tehran Iran
Residency: Internal Medicine, University of Cincinnati, Cincinnati OH
Fellowship: Medical Oncology, Johns Hopkins University, Baltimore
Board certification: American Board of Internal Medicine, American Board of Hematology
Awards
Excellence in Translational Research-Johns Hopkins University
Research Training Award for Fellows-American Society of Hematology
Faculty Teacher of the Year Award-University of Maryland
Memberships and affiliations
American Society of Clinical Oncology
American Society of Hematology
Translational Research Societies
WVU Cancer Institute
West Virginia University School of Medicine; Translational Research Programs